Integrin Signalling in Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 3401
Special Issue Editor
Special Issue Information
Dear Colleagues,
Comprised of 24 members, the integrin family members serve as receptors for various extracellular matrices that allow cells to adhere, create complex structures, and sense their environment. Originally named for their ability to integrate these extracellular signals to the cell’s interior, integrins are responsible for amplifying and potentiating signals from growth factors and other extracellular stimuli that are critical for normal physiology. In fact, there are few, if any, physiological processes that are not influenced by integrin signaling in multicellular organisms. During malignant progression, tumor cells evolve complex interactions with their microenvironment, mediated in large part by integrins that influence progression and define the biology of the tumor. Dissecting the signaling pathways altered by integrin has given and will continue to contribute great insight into the processes that perpetuate a malignant phenotype. As our knowledge of cancer biology increases, so expands the variety of mechanisms we recognize that integrins influence that provide critical insight that may guide how new targeted therapies are devised.
The purpose of this Special Issue is to highlight current research on various and unique aspects of integrin signaling and how this contextual signaling impacts cancer biology including cell motility and invasion, stem cell properties, anoikis, cell proliferation, angiogenesis, metabolism, metastasis, and other important hallmarks of cancer.
Prof. Kathleen L. O'Connor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Integrin
- Cytoskeleton
- Cell motility
- Invasion
- Metastasis
- Anoikis
- Apoptosis
- Cell proliferation
- Therapeutic resistance
- Cancer stem cell
- Signal transduction
- Mechanotransduction
- Transcription
- Epigenetics
- Tumor suppressor
- Oncogene
- Microenvironment
